Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Interest & Investment Income (2020 - 2025)

RxSight's Interest & Investment Income history spans 6 years, with the latest figure at $2.2 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 18.91% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $9.3 million, down 1.49%, while the annual FY2025 figure was $9.3 million, 1.5% down from the prior year.
  • Interest & Investment Income reached $2.2 million in Q4 2025 per RXST's latest filing, down from $2.4 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.9 million in Q3 2024 to a low of $10000.0 in Q4 2021.
  • Average Interest & Investment Income over 5 years is $1.3 million, with a median of $1.6 million recorded in 2023.
  • Peak YoY movement for Interest & Investment Income: crashed 89.8% in 2021, then skyrocketed 8260.0% in 2022.
  • A 5-year view of Interest & Investment Income shows it stood at $10000.0 in 2021, then surged by 8260.0% to $836000.0 in 2022, then skyrocketed by 98.68% to $1.7 million in 2023, then surged by 62.97% to $2.7 million in 2024, then decreased by 18.91% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Interest & Investment Income are $2.2 million (Q4 2025), $2.4 million (Q3 2025), and $2.3 million (Q2 2025).